Agree to Disagree COVID Series: Vaccine Patents

Agree to Disagree COVID Series: Vaccine Paten...

Up next

America 250: Is It Time To Stop Idolizing the Founders?

As America celebrates 250 years since the Declaration of Independence, the legacy of the Founders is under renewed scrutiny. Were they visionary architects of liberty whose achievements and creations should be celebrated, or has reverence for them sanitized the past, how we think ...  Show more

Should the Death Penalty Be Abolished?

Fifty years after the Supreme Court reinstated capital punishment, the death penalty remains one of America's most divisive issues. Supporters argue it delivers justice for the most heinous crimes, provides closure for victims’ families, and ensures the worst offenders can never ...  Show more

Recommended Episodes

Who should control the vaccines?
Business Daily

Calls are rising for a waiver of patent protections on Covid-19 vaccines - but would it do anything to accelerate their rollout in the developing world?Manuela Saragosa speaks to an advocate of the "People's Vaccine" campaign, which aims to end the control of the major pharmaceut ...  Show more

We Can and Must SHARE Vaccines with the Globe
I AM BIO

As the good news about the decline of COVID infections in the US continues to reverberate, the threat of the pandemic still looms globally. “Nobody is safe until everybody is safe.” Sharing life-saving vaccines around the world as quickly as possible defies a simple solution. Thi ...  Show more

Can Africa produce its own Covid vaccines?
Africa Daily

It’s probably fair to say that the one thing the whole world has collectively been thinking about in the last year is Covid and the vaccines that will defeat the infection. Although some countries in Africa have done well at getting their citizens the jab, Africa remains the leas ...  Show more

The Evidence: To boost or not to boost?
Discovery

The divide between the Covid vaccine haves and have-nots has been described as “criminal”, with only 20% of people in low and middle income countries having had one dose, compared with 80% in higher income countries. Countries with high vaccination rates have been called on to gi ...  Show more